Dr. Anthony Traboulsee is a Professor of Neurology and Research Chair of the MS Society of Canada at the University of British Columbia in Vancouver, Canada. He is the Head of the MS and NMO Program at UBC Hospital. He is a neurologist with a research focus the development of practice guidelines for the use of MRI in the management of MS, establishing advanced MRI imaging tools for monitoring remyelination in Multiple Sclerosis, and the treatment of Neuromyelitis Optica. He was the lead author on Consortium of MS Centers international MRI guidelines for diagnosis and treatment of MS and co-author on the International Panel Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorder and the International Panel Diagnostic Criteria for Multiple Sclerosis.
Dr. Traboulsee has been the principal investigator for over 30 clinical trials at UBC. He is a member of the Brain Health in MS international policy report (www.msbrainhealth.org). His overarching treatment philosophy for relapsing MS is to engage patients in personalized treatment goals as early as possible, to use the most effective and safest therapies available, especially during the critical first decade of the disease.